These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21147222)

  • 1. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model.
    Wahlang B; Pawar YB; Bansal AK
    Eur J Pharm Biopharm; 2011 Feb; 77(2):275-82. PubMed ID: 21147222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological barriers to the oral delivery of curcumin.
    Berginc K; Trontelj J; Basnet NS; Kristl A
    Pharmazie; 2012 Jun; 67(6):518-24. PubMed ID: 22822540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the absorption mechanism of solubilized curcumin using Caco-2 cell monolayers.
    Yu H; Huang Q
    J Agric Food Chem; 2011 Sep; 59(17):9120-6. PubMed ID: 21805974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating permeability related hurdles in oral delivery of 11-keto-β-boswellic acid.
    Bagul P; Khomane KS; Bansal AK
    Int J Pharm; 2014 Apr; 464(1-2):104-10. PubMed ID: 24463070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models.
    Sun H; Bi H; Huang M; Liu D; Qin Z
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):486-94. PubMed ID: 20936649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A; Vishwanatha JK
    Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
    Mohanty C; Sahoo SK
    Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of curcumin derivatives in Caco-2 cell monolayers.
    Zeng Z; Shen ZL; Zhai S; Xu JL; Liang H; Shen Q; Li QY
    Eur J Pharm Biopharm; 2017 Aug; 117():123-131. PubMed ID: 28396278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
    Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of curcumin-loaded self-assembled micelles.
    Wang LL; He DD; Wang SX; Dai YH; Ju JM; Zhao CL
    Drug Dev Ind Pharm; 2018 Apr; 44(4):563-569. PubMed ID: 29148846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
    Shelma R; Sharma CP
    Carbohydr Polym; 2013 Jun; 95(1):441-8. PubMed ID: 23618291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?
    Turco L; Catone T; Caloni F; Di Consiglio E; Testai E; Stammati A
    Toxicol In Vitro; 2011 Feb; 25(1):13-20. PubMed ID: 20732406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
    Ma L; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions.
    Yu H; Huang Q
    J Agric Food Chem; 2012 May; 60(21):5373-9. PubMed ID: 22506728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Evaluation of Absorption Characteristics of Peramivir for Oral Delivery.
    Li Y; Wang Z; Li X; Gong W; Xie X; Yang Y; Zhong W; Zheng A
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):757-765. PubMed ID: 28000173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.